Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 149

Humanity’s quest for answers has a new ally: Google’s Willow chip — a quantum chip that outpaces the fastest supercomputers by septillions of years! Imagine solving problems regular computers take years for—like creating life-saving medicines, predicting weather, or designing tech we haven’t dreamed of yet. But with great power comes challenges: high costs, logistics, and even risks to cybersecurity. The quantum revolution has begun, but the big question is—how will we use this power? Palki Sharma tells you.

Google | willow | quantum chip | firstpost | world news | news live | vantage | palki sharma | news.

#google #quantumchip #willow #firstpost #vantageonfirstpost #palkisharma #worldnews.

Vantage is a ground-breaking news, opinions, and current affairs show from Firstpost. Catering to a global audience, Vantage covers the biggest news stories from a 360-degree perspective, giving viewers a chance to assess the impact of world events through a uniquely Indian lens.

The show is anchored by Palki Sharma, Managing Editor, Firstpost.

Read more | >

Researchers at the U.S. Department of Energy’s (DOE) Argonne National Laboratory have developed and demonstrated an innovative set of methods to evaluate long-term aging in real-world battery cells. The methods, described in a recent paper, are based on a phenomenon called nuclear magnetic resonance (NMR), commonly used in medical imaging. This is the first-ever NMRspectroscopy capability that can track in fine detail how the chemistry of commercial pouch battery cells evolves over years of operation.

Argonne develops a novel method that uses nuclear magnetic resonance spectroscopy to characterize the chemical evolution inside battery cells over years of operation.

Read more | >

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”

Currently, heart failure is irreversible. In the absence of a heart transplant, most medical treatments aim to reduce the stress on the heart and slow the progression of the often-deadly disease. But if the gene therapy shows similar results in future clinical trials, it could help heal the hearts of the 1 in 4 people alive today who will eventually develop heart failure.

Read more | >

Just as the metaverse industry finally began its breakthrough, ChatGPT’s launch in November 2022 proved a technological avalanche. Amid post-pandemic economic pressures, companies pivoted away from metaverse aspirations to AI adoption, seeking immediate returns through automation and virtualization.

Apple’s 2023 entry into the space with Vision Pro VR headset has similarly faced challenges. At $3,499, with limited content and a sparse developer ecosystem, Apple struggles to find its market. Early projections suggest initial production runs of fewer than 400,000 units.

What if we’ve been looking for the metaverse in the wrong places? While Meta, HTC and Sony have so far struggled to establish their vision of a VR-first digital world, gaming platforms like Roblox quietly built what might be the actual metaverse.

Read more | >

The study sheds light on mechanisms that could help humans recover from hearing loss.

A new study from USC Stem Cell scientists reveals how certain animals, such as zebrafish and lizards, can regenerate their hearing by reactivating dormant gene regulators.

The discovery provides insight into the mechanisms that could one day help humans recover from hearing loss and balance disorders.

Led by Tuo Shi, Ksenia Gnedeva, and Gage Crump from the Keck School of Medicine of USC, the research focuses on the inner ear’s two critical cell types: sensory cells, which detect sound, and supporting cells, which provide structural and functional support.

Read more | >

Mike has over 15 years of experience in healthcare, including extensive experience designing and developing medical devices. MedCrypt, Inc.

On October 1, 2024, the Food and Drug Administration (FDA) marked a major milestone in medical device cybersecurity enforcement. This marks one year since the retracted Refuse to Accept (RTA) policy and the full implementation of the Protecting and Transforming Cyber Healthcare (PATCH) Act amendment to the Food, Drug & Cosmetic Act (FD&C). The FDA’s new requirements represent a fundamental shift in the regulatory landscape for medical device manufacturers (MDMs), as cybersecurity is now a non-negotiable element of device development and compliance.

The timing is not coincidental. In 2023, the FDA issued its final guidance entitled “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions.” This outlined the detailed cybersecurity requirements and considerations that MDMs must address in their submissions, highlighting the security measures in place to gain regulatory approval. With these requirements, the FDA is taking a hard stance: Cybersecurity is a core consideration, with compliance being systematically enforced.

Read more | >

Kaunas University of Technology (KTU), Lithuania researchers, and scientists from Japan have developed a unique nanolaser. Although the dimensions of this laser are so small that its structure can only be seen through a powerful microscope, its potential is vast. With applications in early medical diagnostics, data communication, and security technologies, this invention could also become a key tool for the study of light and matter interactions.

Depending on the application, lasers differ in the way light is amplified and produced, which determines the color of the radiation and the quality of the laser beam.

“Nanolasers are lasers that use structures a million times smaller than a millimeter to generate and amplify light, and the laser radiation is generated in an extremely tiny volume of material,” says Dr. Mindaugas Juodėnas, one of the authors of the invention.

Read more | >